Showing results (21-30 of 68) with videos related to
Sort By:
Pageof 7
Recent Patents on Anti-Cancer Drug Discovery|August 6, 2016
EGFR and EML4-ALK Updated Therapies in Non-Small Cell Lung CancerRamon Andrade De Mello, Davi J J Liu, Pedro N Aguiar, et al.Oncotarget|November 9, 2017
MicroRNAs in lung cancerDiana Castro, Márcia Moreira, Alexandra Monteiro Gouveia, et al.Oncotargets and Therapy|December 30, 2016
Potential role of immunotherapy in advanced non-small-cell lung cancerRamon Andrade de Mello, Ana Flávia Veloso, Paulo Esrom Catarina, et al.Infection|January 4, 2021
CRISPR-based strategies in infectious disease diagnosis and therapyAlexandra Binnie, Emanuel Fernandes, Helder Almeida-Lousada, et al.Journal of Medical Case Reports|December 25, 2010
Concurrent breast stroma sarcoma and breast carcinoma: a case reportRamon Andrade de Mello, Paulo Figueiredo, Mariela Marques, et al.Pharmacogenomics|November 7, 2013
EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancerRamon Andrade de Mello, Pedro Madureira, Liliana S Carvalho, et al.Plos One|February 12, 2014
Cetuximab plus platinum-based chemotherapy in head and neck squamous cell carcinoma: a retrospective study in a single comprehensive European cancer institutionRamon Andrade de Mello, Sandra Gerós, Marcos Pantarotto Alves, et al.Recent Advances in DNA & Gene Sequences|December 15, 2015
Challenges in Lung Cancer Approaches: from the Clinical Issues to the Novel TherapiesSilvia Patrícia Coelho, Manuel Luis Capelas, Sandra Marlene Alves, et al.Immunotherapy|May 6, 2017
PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: updated survival dataPedro N Aguiar, Ramon Andrade De Mello, Peter Hall, et al.World Journal of Gastroenterology|October 24, 2013
Personalizing therapies for gastric cancer: molecular mechanisms and novel targeted therapiesMichael Luis, Ana Tavares, Liliana S Carvalho, et al.Pageof 7